Candidemia in a Tertiary Care Hospital: Epidemiology and Factors Influencing Mortality

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2003 Apr 24

PMID 12709840

Citations 37

Authors

H Alonso-Valle

O Acha

J D Garcia-Palomo

C Farinas-Alvarez

C Fernandez-Mazarrasa

M C Farinas

Affiliations

Soon will be listed here.

Abstract

The present study was conducted in order to assess the epidemiology and clinical course of candidemia and to identify the risk factors associated with mortality. A total of 143 episodes of nosocomial candidemia were identified during a 5-year period, and these were included in the study. The majority of candidemic episodes were due to Candida albicans (63, 44%), followed by Candida parapsilosis(32, 22%). The overall mortality was 45%. The following independent prognostic factors for mortality were identified: bacterial sepsis, rapidly fatal illness, chronic obstructive lung disease, presence of a central venous catheter, candidemia due to Candida albicans, and lack of antifungal therapy.

Citing Articles

Cold Atmospheric Pressure Plasma May Prevent Oral Mucositis-Related Candidemia in Chemotherapy-Treated Rats.

Sampaio A, Milhan N, do Nascimento F, Kostov K, Koga-Ito C Int J Mol Sci. 2024; 25(21).

PMID: 39519048 PMC: 11546986. DOI: 10.3390/ijms252111496.

Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia.

Theodore D, Henneman A, Loo A, Shields R, Eschenauer G, Sobieszczyk M J Antimicrob Chemother. 2024; 79(8):1877-1884.

PMID: 38831614 PMC: 11290885. DOI: 10.1093/jac/dkae175.

Sequence Variation of Candida albicans Sap2 Enhances Fungal Pathogenicity via Complement Evasion and Macrophage M2-Like Phenotype Induction.

Lin L, Wang M, Zeng J, Mao Y, Qin R, Deng J Adv Sci (Weinh). 2023; 10(20):e2206713.

PMID: 37211685 PMC: 10369283. DOI: 10.1002/advs.202206713.

Growth and Antifungal Resistance of the Pathogenic Yeast, , in the Microgravity Environment of the International Space Station: An Aggregate of Multiple Flight Experiences.

Nielsen S, White K, Preiss K, Peart D, Gianoulias K, Juel R Life (Basel). 2021; 11(4).

PMID: 33801697 PMC: 8067245. DOI: 10.3390/life11040283.

Portuguese honeys as antimicrobial agents against species.

Fernandes L, Ribeiro H, Oliveira A, Sanches Silva A, Freitas A, Henriques M J Tradit Complement Med. 2021; 11(2):130-136.

PMID: 33728273 PMC: 7936102. DOI: 10.1016/j.jtcme.2020.02.007.

References

Edwards Jr J, Bodey G, Bowden R, Buchner T, De Pauw B, Filler S . International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis. 1997; 25(1):43-59. DOI: 10.1086/514504. View

Fridkin S, Jarvis W . Epidemiology of nosocomial fungal infections. Clin Microbiol Rev. 1996; 9(4):499-511. PMC: 172907. DOI: 10.1128/CMR.9.4.499. View

Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S . The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997; 24(6):1122-8. DOI: 10.1086/513663. View

Vincent J, Bihari D, Suter P, Bruining H, White J, Wolff M . The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995; 274(8):639-44. View

Pfaller M, Jones R, Doern G, Sader H, Hollis R, Messer S . International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY.... J Clin Microbiol. 1998; 36(7):1886-9. PMC: 104946. DOI: 10.1128/JCM.36.7.1886-1889.1998. View

Wey S, Mori M, Pfaller M, Woolson R, Wenzel R . Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 1988; 148(12):2642-5. DOI: 10.1001/archinte.148.12.2642. View

Banerjee S, Emori T, Culver D, Gaynes R, Jarvis W, Horan T . Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med. 1991; 91(3B):86S-89S. DOI: 10.1016/0002-9343(91)90349-3. View

Harvey R, Myers J . Nosocomial fungemia in a large community teaching hospital. Arch Intern Med. 1987; 147(12):2117-20. View

Garner J, Jarvis W, Emori T, Horan T, Hughes J . CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16(3):128-40. DOI: 10.1016/0196-6553(88)90053-3. View

10.

Jarvis W . Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995; 20(6):1526-30. DOI: 10.1093/clinids/20.6.1526. View

11.

Wey S, Mori M, Pfaller M, Woolson R, Wenzel R . Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989; 149(10):2349-53. View

12.

Klein J, Watanakunakorn C . Hospital-acquired fungemia. Its natural course and clinical significance. Am J Med. 1979; 67(1):51-8. DOI: 10.1016/0002-9343(79)90073-1. View

13.

Pittet D, Costigan M, Hwang T, Davis C, Wenzel R . The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995; 273(2):117-23. View

14.

Fraser V, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan W . Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 1992; 15(3):414-21. DOI: 10.1093/clind/15.3.414. View

15.

Weems Jr J . Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis. 1992; 14(3):756-66. DOI: 10.1093/clinids/14.3.756. View